Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Transplant Proc ; 48(5): 1431-4, 2016 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-27496422

RESUMEN

BACKGROUND: Chronic kidney disease is one of the medical conditions that affect hemostasis. Patients undergoing hemodialysis present both hemorrhagic and prothrombotic tendencies. Platelet adhesion to the artificial surface of the dialyzer's membrane, blood vessel endothelial wall disruption, and quantitative and qualitative changes in clothing factors are thought to be causative agents of the above-mentioned conditions. Thromboelastometry and impedance aggregometry enable precise assessment of clot formation and platelet function abnormalities, including changes related to chronic renal failure in patients undergoing renal replacement therapy. METHODS: A prospective study with control group was designed. The study group consisted of 17 adults with diagnosed chronic renal failure undergoing hemodialysis. The control group consisted of 13 healthy volunteers. EXTEM and FIBTEM tests in rotational thromboelastometry and TRAPtest in impedance aggregometry analyzer were performed. RESULTS: EXTEM parameter test results were comparable between analyzed groups, whereas FIBTEM test results were significantly increased in the study group. Platelet aggregation as measured by the TRAPtests was significantly decreased in patients undergoing hemodialysis. CONCLUSIONS: In end-stage renal disease patients undergoing hemodialysis, whole-blood clot formation is not disturbed, even though platelet dysfunction occurs. Increased fibrin clot formation reflected by FIBTEM results may compensate the observed platelet disorders. The compilation of ROTEM and Multiplate may support appropriate hemostatic control and decision-making during kidney transplantation.


Asunto(s)
Hemostasis , Fallo Renal Crónico/sangre , Trasplante de Riñón , Diálisis Renal , Tromboelastografía/métodos , Adulto , Anciano , Coagulación Sanguínea , Pruebas de Coagulación Sanguínea , Plaquetas , Estudios de Casos y Controles , Impedancia Eléctrica , Femenino , Humanos , Fallo Renal Crónico/terapia , Masculino , Persona de Mediana Edad , Agregación Plaquetaria , Recuento de Plaquetas , Pruebas de Función Plaquetaria , Periodo Preoperatorio , Estudios Prospectivos
2.
Transplant Proc ; 48(5): 1692-6, 2016 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-27496473

RESUMEN

BACKGROUND: Early extubation is a standard procedure after liver transplantation (LT). METHODS: The preoperative and perioperative data of 506 adult patients undergoing LT from July 2000 to March 2015 were analyzed. The goal of this study was to determine preoperative and perioperative independent predictors of early tracheal extubation. RESULTS: Of the 506 study patients, 73.7% were extubated early after LT. Patients in this group exhibited better preoperative and perioperative outcomes. However, according to multivariate logistic regression analysis, only 3 parameters were independent predictors of early extubation: initial hemoglobin concentration (odds ratio [OR], 1.187 [95% confidence interval (CI), 1.033-1.364]), application of epidural anesthesia (OR, 2.762 [95% CI, 1.025-7.445), and units of perioperative packed red blood cells and fresh frozen plasma transfused (OR, 0.919 [95% CI, 0.888-0.952]). CONCLUSIONS: Early extubation of patients undergoing LT is a safe and widely used procedure. However, the decision regarding this procedure should be made after thorough analysis of the patient's current status, the course of operation, and the patient's preoperative parameters. Based on our findings, we believe that the decision regarding early extubation can be aided by taking into account the patient's initial hemoglobin concentration, the number of packed red blood cells and fresh frozen plasma transfused during surgery, and pain control by application of a thoracic epidural catheter.


Asunto(s)
Extubación Traqueal/métodos , Trasplante de Hígado , Adulto , Anciano , Femenino , Humanos , Trasplante de Hígado/métodos , Masculino , Persona de Mediana Edad , Oportunidad Relativa , Factores de Tiempo
3.
Transplant Proc ; 38(1): 234-6, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-16504711

RESUMEN

INTRODUCTION: Our previous studies showed a correlation of intraoperative renal allograft blood flow and immediate functions. A similar relation is not well established for liver transplantation. The aim of this study was to assess the relation between hepatic blood flow on revascularization and immediate liver graft function (IF). METHODS: Studies evaluating arterial and portal flow in newly transplanted livers were started in May 2004. Total hepatic artery and portal vein blood flow were assessed in 15 liver transplant recipients. Parenchymal flow was also recorded. Measurements were taken at 30 and 120 minutes after simultaneous arterial/portal reperfusion. Flow results were correlated with IF. RESULTS: Mean arterial blood flow (ABF) was 16.3 mL/min/100 g in both measurements. Portal flow was reduced from 168 to 127 mL/min/100 g from the first to the second measurement. Mean parenchymal flow (PF) did not alter over time (29.1 and 30.4 mL/min/100 g, respectively). Among recorded flow results we observed a significant correlation between PF with IF measured as: bile volume (R = 0.36 to 0.62; P < .05), serum AST (R = -0.4 to -0.68; P < .05), and ALT level (R = -0.2 to -0.71; P < .05), bilirubin level as well as INR (R = -0.39 to -0.61; P < .05) assayed daily for 14 days. Similar observations were made between ABF and INR, hiatal parenchymal flow, and ALT as well as INR. CONCLUSIONS: These preliminary results suggest hepatic blood flow may be a reliable predictor of graft viability and function. Of the variables measured, portal blood flow seems to be the most valuable indicator of liver function.


Asunto(s)
Velocidad del Flujo Sanguíneo , Arteria Hepática/fisiopatología , Trasplante de Hígado/fisiología , Vena Porta/fisiopatología , Bilis/metabolismo , Supervivencia de Injerto/fisiología , Hemodinámica , Humanos , Periodo Intraoperatorio , Pruebas de Función Hepática , Trasplante Homólogo
4.
Ann Transplant ; 8(4): 40-2, 2003.
Artículo en Inglés | MEDLINE | ID: mdl-15171005

RESUMEN

Recombinant activated factor VII (rFVIIa, NovoSeven, Novo Nordisk A/S, Denmark) is a treatment used to prevent and arrest intra- and postoperative bleeds in patients with haemophilia A or B complicated by circulating anticoagulants (inhibitors of FVIII and FIX). Patients who qualify for liver transplantation may have varying degrees of coagulation impairment, which may adversely impact elective anaesthetic and surgical procedures and elevate the risk of intraoperative bleeds, which require massive blood transfusions and worsen prognosis. Recently, reports have been published on the use of rFVIIa prior to surgical procedures, which are likely to cause severe blood loss as well as for so-called emergency therapy of coagulation disorders during liver transplantation.


Asunto(s)
Factor VIIa/uso terapéutico , Trasplante de Hígado/métodos , Adolescente , Adulto , Trastornos de la Coagulación Sanguínea/tratamiento farmacológico , Hepatitis C Crónica/sangre , Hepatitis C Crónica/cirugía , Degeneración Hepatolenticular/sangre , Degeneración Hepatolenticular/cirugía , Humanos , Fallo Hepático/sangre , Fallo Hepático/cirugía , Masculino , Persona de Mediana Edad , Hemorragia Posoperatoria/prevención & control , Proteínas Recombinantes/uso terapéutico
5.
Ann Transplant ; 7(3): 52-4, 2002.
Artículo en Inglés | MEDLINE | ID: mdl-12465434

RESUMEN

Recombinant activated factor VII (rFVIIa, NovoSeven, Novo Nordisk A/S, Denmark) is a treatment used to prevent and arrest intra- and postoperative bleeding in patients with haemophilia A or B complicated by circulating anticoagulants (inhibitors of FVIII and FIX) and in patients without haemophilia who spontaneously develop inhibitors of FVIII, i.e. in acquired haemophilia. Patients who qualify for liver transplantation due to liver dysfunction may have varying degrees of coagulation impairment and thus carry an elevated risk of massive bleeding and have worse prognosis. The authors administered recombinant activated factor VII to two patients with coagulation abnormalities in the course of Wilson's disease during liver transplantation.


Asunto(s)
Pérdida de Sangre Quirúrgica/prevención & control , Factor VII/uso terapéutico , Hemostasis Quirúrgica/métodos , Degeneración Hepatolenticular/cirugía , Trasplante de Hígado/métodos , Adolescente , Adulto , Femenino , Humanos , Periodo Intraoperatorio , Proteínas Recombinantes/uso terapéutico
6.
Pediatr Hematol Oncol ; 17(8): 673-8, 2000 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-11127399

RESUMEN

The diagnosis of neuroblastoma in its early stage, especially in asymptomatic children, with the so-called incidentally diagnosed disease, may be associated with a good prognosis. The aim of this study is an attempt at analyzing this problem. Between 1 January 1993 and 30 April 1998, 40 children with newly diagnosed neuroblastoma started therapy at the authors' department. The disease was diagnosed incidentally in 5 (12.5%) patients. In no incidentally diagnosed child was stage IV disease detected, while in the remaining patients its incidence was 71%. All the children (median age 2 months) with incidental diagnosis have remained alive (median 39 months) in continuous remission without treatment. Among 35 children (median age 2 years and 7 months) with overt neuroblastoma, 18 died (median survival time 14.5 months). Seventeen patients have remained alive (median 45 months). The results show that children with incidentally diagnosed neuroblastoma are characterized by a more favorable prognosis than children with clinical disease.


Asunto(s)
Neuroblastoma/diagnóstico , Humanos , Lactante , Recién Nacido , Neuroblastoma/mortalidad , Neuroblastoma/terapia , Pronóstico , Inducción de Remisión , Tasa de Supervivencia
7.
Ginekol Pol ; 71(7): 599-603, 2000 Jul.
Artículo en Polaco | MEDLINE | ID: mdl-11002567

RESUMEN

The influence of lactation on the age of menopause has been estimated in the representative group of 120 women hospitalised because of climacteric complaints. The diagnosis of menopause has been based on the history of a patient and gynaecological examination and Kupperman index or on the estradiol and gonadothropin levels. Observation of menopausal patients reveals correlation between neuroendocrine complaints and symptoms in the climacteric syndrome and pregnancy dependent hypothalamus failure. According to the results of this analysis, shortened period of lactation correlates with earlier onset of menopause and duration of the lactation has a greater effect on menopause than course of labour.


Asunto(s)
Lactancia/fisiología , Menopausia/fisiología , Adulto , Factores de Edad , Anciano , Femenino , Humanos , Persona de Mediana Edad , Embarazo
8.
Pol Merkur Lekarski ; 2(8): 113-5, 1997 Feb.
Artículo en Polaco | MEDLINE | ID: mdl-9538654

RESUMEN

The results of treatment in 45 children with rhabdomyosarcoma was presented. Two-years survival was achieved in 63% and five-year in 45%. The importance of location and group of clinical progression discussed was importance prognostic factors in rhabdomyosarcoma.


Asunto(s)
Rabdomiosarcoma/mortalidad , Rabdomiosarcoma/terapia , Adolescente , Quimioterapia Adyuvante , Niño , Preescolar , Terapia Combinada , Progresión de la Enfermedad , Femenino , Humanos , Lactante , Masculino , Polonia/epidemiología , Pronóstico , Radioterapia Adyuvante , Distribución por Sexo , Tasa de Supervivencia , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA